Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Bsf Enterprise Plc operates as a biotechnology company, primarily focused on the development of innovative bio-derived alternatives and materials. Its core purpose is to advance sustainable technologies and solutions that align with the growing demand for eco-friendly products. Catering to multiple industries including agriculture, pharmaceuticals, and cosmetics, Bsf Enterprise Plc pioneers the creation of biological substances that can replace traditional chemical counterparts. The company’s emphasis on research and development underscores its commitment to unlocking new, environmentally beneficial applications and ensuring the viability and scalability of its products. In the financial market, Bsf Enterprise Plc is recognized for its contributions to the rising biotech sector, which is seeing increased interest due to the global push for sustainability and green technology solutions. As such, its developments play a crucial role in enhancing resource efficiency and reducing environmental footprints, positioning it as a significant player in the transformation toward a more sustainable economy.
£0.01
£0.00 (-5.12%)
EOD Jul 3, 2026
The business is unprofitable at the operating level (-2298.22% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 8.6% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -£1M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
£53K
▼ -8.6% YoY
Net Income (TTM)
-£1M
▲ +33.4% YoY
Op. Margin
-2298.22%
▲ +794.0pp YoY
ROIC
-32.05%
▲ +2.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-£1M
▲ +36.4% YoY
Op. Cash Flow (TTM)
-£1M
▲ +36.6% YoY
Net Debt
-£149K
Net Cash Position
Cash & Equiv.
£149K
Continue Research
Bsf Enterprise (BSFA.XLON)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Bsf Enterprise scores 10/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Bsf Enterprise scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 4 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -2,298.2% operating margin and a -32.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh BSFA.XLON's valuation and scores 10/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.